Sign in
  Edit search
Idebenone as a novel%25252C therapeutic approach for Duchenn…
Idebenone as a novel%25252C therapeutic approach for Duchenne muscular dystrophy%25253A results from a 12 month%25252C double-blind%25252C randomized placebo-controlled trial
Idebenone as a novel%25252C therapeutic approach for Duchenne muscular dystrophy%25253A results from a 12 month%25252C double-blind%25252C randomized placebo-controlled trial
Article, Chapter
Authors: G.M. Buyse
Publication: Neuromuscular Disorders, Volume:21, Issue:6, Page(s):-405
Published: Elsevier, 2011
ISSN: 0960-8966
  Full text availability for this item
View Full Text Source:Neuromuscular Disorders,Neuromuscular Disorders,Elsevier ScienceDirect Journals Opens in new Window
Journal:  Neuromuscular Disorders Source:Elsevier ScienceDirect Journals Opens in new Window
Collection:  Elsevier ScienceDirect Journals Opens in new Window
Coverage:
  • 1991~present; volume:1~present;issue:1~present
Browse related articles
  Print copies at your library
Check availability in RUQuest
  Request a copy of this item
Cite this item